Canada - English - Health Canada

laboratoires confab inc - dimenhydrinate - suppository - 100mg - dimenhydrinate 100mg - antihistamines

Ireland - English - HPRA (Health Products Regulatory Authority)

alk-abello a/s - apis mellifera - suspension for injection - 100,000 - insects

Ireland - English - HPRA (Health Products Regulatory Authority)

alk-abello a/s - apis mellifera; apis mellifera; apis mellifera; apis mellifera - suspension for injection - 100,000 - insects

Ireland - English - HPRA (Health Products Regulatory Authority)

alk-abello a/s - vespula spp. - suspension for injection - 100,000 - insects

Ireland - English - HPRA (Health Products Regulatory Authority)

alk-abello a/s - vespula spp.; vespula spp.; vespula spp.; vespula spp. - suspension for injection - 100,000 - insects

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - betula papyrifera, quantity: 1.7 ml (equivalent: betula papyrifera, qty 17 mg/ml); betula nigra, quantity: 1.7 ml (equivalent: betula nigra, qty 17 mg/ml); betula pendula, quantity: 1.7 ml (equivalent: betula pendula, qty 17 mg/ml) - extract, liquid - excipient ingredients: glycerol; sodium chloride; sodium bicarbonate; water for injections - indicated use of allergenic extracts is for the diagnosis and treatment (hypo-sensitization therapy) of patients who experience allergic symptoms.

Canada - English - Health Canada

allergy therapeutics (uk) ltd - modified ragweed tyrosine adsorbate; modified ragweed tyrosine adsorbate; modified ragweed tyrosine adsorbate; modified ragweed tyrosine adsorbate - liquid - 210unit; 500unit; 1400unit; 4300unit - modified ragweed tyrosine adsorbate 210unit; modified ragweed tyrosine adsorbate 500unit; modified ragweed tyrosine adsorbate 1400unit; modified ragweed tyrosine adsorbate 4300unit - allergenic extracts

United States - English - NLM (National Library of Medicine)

nelco laboratories, inc. - aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48) - aspergillus fumigatus 0.05 g in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

United States - English - NLM (National Library of Medicine)

nelco laboratories, inc. - bos taurus skin (unii: 7j12cd6o9l) (bos taurus skin - unii:7j12cd6o9l) - bos taurus skin 20000 [pnu] in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

United States - English - NLM (National Library of Medicine)

nelco laboratories, inc. - common carp (unii: zb2sv6jjy5) (common carp - unii:zb2sv6jjy5) - common carp 0.1 g in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t